Chronic HIV co-infection and the treatment of chronic inflammatory conditions such as rheumatoid arthritis with potent immune modulators such as anti-TNF biologics, has revealed latent Mycobacterium tuberculosis (M.tb) infection reactivation as another growing source of TB disease burden, compounded by the global rise of drug-resistant TB. The gene discussed is TNF; the disease is tuberculosis.